Antiviral activity of Ferula assa-feotida on HSV-1, 2 in vitro

Background and Objectives: Medicinal plants are the primary treatment for many infectious and non-infectious diseases. In this study, we evaluated the antiviral activity of Ferula assa-feotida against herpes simplex viruses 1 and 2, and compared it with the antiviral drug acyclovir. Materials and M...

Full description

Saved in:
Bibliographic Details
Main Authors: Javad Charostad, Tahere Navidfar, Masoumeh Kiani, Paul Schinitzler, Akram Astani
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2024-12-01
Series:Iranian Journal of Microbiology
Subjects:
Online Access:https://ijm.tums.ac.ir/index.php/ijm/article/view/4559
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841558585268502528
author Javad Charostad
Tahere Navidfar
Masoumeh Kiani
Paul Schinitzler
Akram Astani
author_facet Javad Charostad
Tahere Navidfar
Masoumeh Kiani
Paul Schinitzler
Akram Astani
author_sort Javad Charostad
collection DOAJ
description Background and Objectives: Medicinal plants are the primary treatment for many infectious and non-infectious diseases. In this study, we evaluated the antiviral activity of Ferula assa-feotida against herpes simplex viruses 1 and 2, and compared it with the antiviral drug acyclovir. Materials and Methods: In our experimental study, Ferula assa-feotida was dissolved in DMSO, then diluted in DMEM medium. Acyclovir was used at a concentration of 100 μM in all procedures. The antiherpetic activity and Antiviral activity of Ferula were evaluated in Vero cells (African green monkey kidney cells) by using the plaque reduction assay. Results: Inhibitory concentrations of 50% (IC50) of Ferula assa-feotida for HSV-1 and HSV-2 were determined at 0.00025% and 0.00015%, respectively. Ferula was introduced at various stages of viral infection and significantly inhibited HSV-1 and HSV-2 infectivity by > 95.5% and 89%, respectively, when virus was pre-treated before addition to the cells. No HSV-1 or HSV-2 activity was detected in cells treated prior to and following viral infection. Conclusion: These results indicate that Ferula assa-feotida demonstrates antiherpetic activity in the early phase of viral infection and could be used as potential antiviral agent.
format Article
id doaj-art-4233295fa0ed49a5bf1ed1184459e241
institution Kabale University
issn 2008-3289
2008-4447
language English
publishDate 2024-12-01
publisher Tehran University of Medical Sciences
record_format Article
series Iranian Journal of Microbiology
spelling doaj-art-4233295fa0ed49a5bf1ed1184459e2412025-01-06T08:38:45ZengTehran University of Medical SciencesIranian Journal of Microbiology2008-32892008-44472024-12-0116610.18502/ijm.v16i6.17257Antiviral activity of Ferula assa-feotida on HSV-1, 2 in vitroJavad Charostad0Tahere Navidfar1Masoumeh Kiani2Paul Schinitzler3Akram Astani4Department of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, IranDepartment of Basic Sciences, Shoushtar Faculty of Medical Sciences, Shushtar University of Medical and Science, Shushtar, IranDepartment of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, IranDepartment of Infectious Diseases, Virology, University of Heidelberg, Heidelberg, GermanyDepartment of Microbiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran; Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran Background and Objectives: Medicinal plants are the primary treatment for many infectious and non-infectious diseases. In this study, we evaluated the antiviral activity of Ferula assa-feotida against herpes simplex viruses 1 and 2, and compared it with the antiviral drug acyclovir. Materials and Methods: In our experimental study, Ferula assa-feotida was dissolved in DMSO, then diluted in DMEM medium. Acyclovir was used at a concentration of 100 μM in all procedures. The antiherpetic activity and Antiviral activity of Ferula were evaluated in Vero cells (African green monkey kidney cells) by using the plaque reduction assay. Results: Inhibitory concentrations of 50% (IC50) of Ferula assa-feotida for HSV-1 and HSV-2 were determined at 0.00025% and 0.00015%, respectively. Ferula was introduced at various stages of viral infection and significantly inhibited HSV-1 and HSV-2 infectivity by > 95.5% and 89%, respectively, when virus was pre-treated before addition to the cells. No HSV-1 or HSV-2 activity was detected in cells treated prior to and following viral infection. Conclusion: These results indicate that Ferula assa-feotida demonstrates antiherpetic activity in the early phase of viral infection and could be used as potential antiviral agent. https://ijm.tums.ac.ir/index.php/ijm/article/view/4559Ferula assa-foetida;Antiviral;Herpes simplex virus type 1;Herpes simplex virus type 2
spellingShingle Javad Charostad
Tahere Navidfar
Masoumeh Kiani
Paul Schinitzler
Akram Astani
Antiviral activity of Ferula assa-feotida on HSV-1, 2 in vitro
Iranian Journal of Microbiology
Ferula assa-foetida;
Antiviral;
Herpes simplex virus type 1;
Herpes simplex virus type 2
title Antiviral activity of Ferula assa-feotida on HSV-1, 2 in vitro
title_full Antiviral activity of Ferula assa-feotida on HSV-1, 2 in vitro
title_fullStr Antiviral activity of Ferula assa-feotida on HSV-1, 2 in vitro
title_full_unstemmed Antiviral activity of Ferula assa-feotida on HSV-1, 2 in vitro
title_short Antiviral activity of Ferula assa-feotida on HSV-1, 2 in vitro
title_sort antiviral activity of ferula assa feotida on hsv 1 2 in vitro
topic Ferula assa-foetida;
Antiviral;
Herpes simplex virus type 1;
Herpes simplex virus type 2
url https://ijm.tums.ac.ir/index.php/ijm/article/view/4559
work_keys_str_mv AT javadcharostad antiviralactivityofferulaassafeotidaonhsv12invitro
AT taherenavidfar antiviralactivityofferulaassafeotidaonhsv12invitro
AT masoumehkiani antiviralactivityofferulaassafeotidaonhsv12invitro
AT paulschinitzler antiviralactivityofferulaassafeotidaonhsv12invitro
AT akramastani antiviralactivityofferulaassafeotidaonhsv12invitro